Mobile Technology for Reducing and Preventing Adolescent Suicide

摘要 自杀是美国青少年的两大死因，青少年自杀率稳步上升 增加了。尽管如此，关于旨在减少自杀的移动技术的研究还很少 年轻人之间的尝试。在此第一阶段SBIR应用程序OUI Treateutics中，LLC提出了一个项目以：1)创建 针对青少年(13-17岁)的Aviva-Y测试版；和2)测试测试版的可行性和可接受性 单组开放标签试验中的英杰华-Y版本。成功执行该第一阶段项目的目标 将产生一种版本的Aviva-Y，准备在临床试验中对病情稳定的患者进行疗效测试。 长远来说，这个项目将通过以下途径对青少年自杀预防领域产生有益的影响 发展移动技术，旨在推进有效的交付和传播 干预措施。

ABSTRACT Suicide is a top two cause of death in the US for adolescents and suicide rates among youth have steadily increased. Despite this, there is a paucity of research on mobile technology designed to reduce suicide attempts among youth. In this Phase I SBIR application Oui Therapeutics, LLC proposes a project to: 1) Create a beta version of Aviva-Y for youth (ages 13 - 17); and 2) to test the feasibility and acceptability of the beta version of Aviva-Y in a single-group, open-label trial. Successful execution of the goals of this Phase I project will generate a version of Aviva-Y that is ready to be tested for efficacy with stabilized patients in a clinical trial. In the long term, this project will have a beneficial impact on the field of youth suicide prevention through the development of mobile technology designed to advance the delivery and dissemination of effective interventions.